21–29 associated with the binding of retinoblastoma (Rb) tumor suppressor, since E7 acts as the major immortalizing protein through Rb/E2F pathway, amino acid alternations in Rb binding domain may lead to the change of E7′s ability to immortalize cells among variants [34]. The gene discussed is RB1; the disease is neoplasm.